LONG FACTOR CERTIFICATE - PFIZER INC Share Price

Certificat

Y2A8H

DE000GQ8X3T6

Market Closed - Euronext Paris 17:30:02 14/06/2024 BST
0.07 EUR -12.50% Intraday chart for LONG FACTOR CERTIFICATE - PFIZER INC
Current month-52.94%
1 month-66.67%
Date Price Change
14/06/24 0.08 0.00%
13/06/24 0.08 -11.11%
12/06/24 0.09 -18.18%
11/06/24 0.11 +10.00%
10/06/24 0.1 -41.18%

Real-time Euronext Paris

Last update June 14, 2024 at 05:30 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Goldman Sachs
Y2A8H
ISINDE000GQ8X3T6
Date issued 13/11/2023
Strike 25.82 $
Maturity Unlimited
Parity 21.36 : 1
Emission price 21.96
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 30.28
Lowest since issue 0.01
Spread 0.01
Spread %11.11%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.53 USD
Average target price
31.92 USD
Spread / Average Target
+15.93%
Consensus
  1. Stock Market
  2. Certificates
  3. Y2A8H Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW